Press Release FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL) 14 May 2025
Press Release The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1 14 May 2025
Press Release AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause 14 May 2025
Press Release Binarly Patents New Method for Reachability Analysis for Binary Executables 14 May 2025
Press Release U-Haul Holding Company Schedules Fourth Quarter Fiscal Year End 2025 Financial Results Release and Investor Webcast 14 May 2025
Press Release Texas Lawmakers Unite to Recognize May 14 as Moral Injury Awareness Day Statewide 14 May 2025
